The Europe immunohistochemistry market is expected to grow from US$ 631.33 million in 2021 to US$ 1,022.27 million by 2028; it is estimated to grow at a CAGR of 7.1% from 2021 to 2028.
The UK, Germany, France, Italy, and Spain are major economies in Europe. Growing R&D investments by biotechnology & biopharmaceutical companies is expected to fuel the market growth. In recent years, the biotechnology industry is developing at an extraordinarily rapid speed. Manufacturers are confronting to the various healthcare difficulties through the latest medicines, progressing digitalization, therapy forms, and continuously changing the management. As per the statistics from the World Health Organization (WHO), the population is rising by 1.2% per annum, leading to growth in population in the elderly class. The WHO also reveals that the balance of people aged 65 to 80 will increase to 28% in 2030, as compared to 22% in 2000. Additionally, rising urbanization and a growing number of middle-income people results in drug makers manufacturing reasonable medicines is responsible to drive the growth of the market. These formulations are produced in the market after passing through strict regulatory guidelines for patient safety. Research & development expenses compared to the methods of exploring, examining, and producing innovative products, upfront payments, and milestones, enhancing products, and exhibiting product efficiency and regulatory compliance before launch. Thus, the high research investment by investors, biopharmaceutical, and biotechnology industries are expected to propel the growth of the immunohistochemistry market over the forecast years. The increasing investments in R&D activities have paved the way for the growth of the industry in the future years. Many scientists, in partnership with other scientists, offer various products for bioreactors. These factors are expected to increase biotechnology and biopharmaceutical industries to achieve efficient tests which are predicted to drive the growth of the Europe market.Countries in Europe, especially France, are highly affected due to the COVID-19 outbreak. Coronavirus immunohistochemistry antibodies are immunological methods that can be used to identify members of the Coronaviridae family of RNA viruses that infect birds and mammals. Antibodies against antigens expressed by several coronavirus strains, such as SARS-CoV-2, SARS-CoV, MERS, and other non-human pathogens like feline coronavirus, are listed below. Common coronavirus antibody targets include nucleocapsid (N) and spike glycoprotein (S). These antibodies are intended for immunohistochemical applications. Immunohistochemistry analysis shows the detection of differential expression levels of SARS-CoV-2 Coronavirus Nucleocapsid and demonstrates antibody specificity. Immunohistochemical analysis of SARS-CoV-2 Coronavirus NP using SARS/SARS-CoV-2 Coronavirus NP Monoclonal Antibody (B46F) (Cat. No. MA1-7404) shows significant staining in human lung and placenta tissues infected with SARS-CoV-2 when compared to the control tissues without SARS-CoV-2. Researchers from the UK and Sweden recently used extremely sensitive multiplexed immunohistochemistry to examine ACE2 expression in brain pericytes of patients with neurological symptoms in COVID-19 patients and controls. They also used spatial immunophenotyping to evaluate inflammation in COVID-19 patients' brain tissue.
With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the Europe immunohistochemistry market. The Europe immunohistochemistry market is expected to grow at a good CAGR during the forecast period.
- This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.
Europe Immunohistochemistry Market Segmentation
Europe Immunohistochemistry Market – By Product
- Equipment
- Slide Staining Systems
- Tissue Microarray Systems
- Tissue Processing Systems
- Slide Scanners
- Other Equipment
- Antibodies
- Primary Antibodies
- Secondary Antibodies
- Reagents
- Histological Stains
- Blocking and Fixation Reagents
- Chromogenic Substrates
- Fixation Reagents
- Stabilizers
- Organic Solvents
- Proteolytic Enzymes
- Diluents
- Kits
Europe Immunohistochemistry Market – By Application
- Diagnostics
- Cancer
- Infectious Diseases
- Autoimmune Diseases
- Diabetes Mellitus
- Nephrological Diseases
- Others
- Drug Testing
Europe Immunohistochemistry Market – By End User
- Hospitals and Diagnostic Laboratories
- Research Institutes
- Others
Europe Immunohistochemistry Market, by Country
- UK
- Germany
- France
- Italy
- Spain
- Rest of Europe
Europe Immunohistochemistry Market - Companies Mentioned
- Abcam plc
- Agilent Technologies, Inc.
- Bio SB
- BIO-RAD LABORATORIES INC.
- Cell Signaling Technology, Inc.
- Danaher
- F. HOFFMANN-LA ROCHE LTD.
- MERCK KGaA
- PerkinElmer Inc.
- THERMO FISHER SCIENTIFIC INC.
Europe Immunohistochemistry Report Scope
Report Attribute | Details |
---|---|
Market size in 2021 | US$ 631.33 Million |
Market Size by 2028 | US$ 1,022.27 Million |
Global CAGR (2021 - 2028) | 7.1% |
Historical Data | 2019-2020 |
Forecast period | 2022-2028 |
Segments Covered |
By Application
|
Regions and Countries Covered | Europe
|
Market leaders and key company profiles |
- Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
- PEST and SWOT Analysis
- Market Size Value / Volume - Global, Regional, Country
- Industry and Competitive Landscape
- Excel Dataset
Testimonials

I wish to appreciate your support and the professionalism you displayed in the course of attending to my request for information regarding to infectious disease IVD market in Nigeria. I appreciate your patience, your guidance, and the fact that you were willing to offer a discount, which eventually made it possible for us to close a deal. I look forward to engaging The Insight Partners in the future, all thanks to the impression you have created in me as a result of this first encounter.
DR CHIJIOKE ONYIA, MANAGING DIRECTOR, PineCrest Healthcare Ltd.
The Insight Partners delivered insightful, well-structured market research with strong domain expertise. Their team was professional and responsive throughout. The user-friendly website made accessing industry reports seamless. We highly recommend them for reliable, high-quality research services
Yukihiko Adachi CEO, Deep Blue, LLC.Reason to Buy
- Informed Decision-Making
- Understanding Market Dynamics
- Competitive Analysis
- Customer Insights
- Market Forecasts
- Risk Mitigation
- Strategic Planning
- Investment Justification
- Identifying Emerging Markets
- Enhancing Marketing Strategies
- Boosting Operational Efficiency
- Tracking Industry Innovations
- Aligning with Regulatory Trends
Yes! We provide a free sample of the report, which includes Report Scope (Table of Contents), report structure, and selected insights to help you assess the value of the full report. Please click on the "Download Sample" button or contact us to receive your copy.
Absolutely — analyst assistance is part of the package. You can connect with our analyst post-purchase to clarify report insights, methodology or discuss how the findings apply to your business needs.
Once your order is successfully placed, you will receive a confirmation email along with your invoice.
• For published reports: You’ll receive access to the report within 4–6 working hours via a secured email sent to your email.
• For upcoming reports: Your order will be recorded as a pre-booking. Our team will share the estimated release date and keep you informed of any updates. As soon as the report is published, it will be delivered to your registered email.
We offer customization options to align the report with your specific objectives. Whether you need deeper insights into a particular region, industry segment, competitor analysis, or data cut, our research team can tailor the report accordingly. Please share your requirements with us, and we’ll be happy to provide a customized proposal or scope.
The report is available in either PDF format or as an Excel dataset, depending on the license you choose.
The PDF version provides the full analysis and visuals in a ready-to-read format. The Excel dataset includes all underlying data tables for easy manipulation and further analysis.
Please review the license options at checkout or contact us to confirm which formats are included with your purchase.
Our payment process is fully secure and PCI-DSS compliant.
We use trusted and encrypted payment gateways to ensure that all transactions are protected with industry-standard SSL encryption. Your payment details are never stored on our servers and are handled securely by certified third-party processors.
You can make your purchase with confidence, knowing your personal and financial information is safe with us.
Yes, we do offer special pricing for bulk purchases.
If you're interested in purchasing multiple reports, we’re happy to provide a customized bundle offer or volume-based discount tailored to your needs. Please contact our sales team with the list of reports you’re considering, and we’ll share a personalized quote.
Yes, absolutely.
Our team is available to help you make an informed decision. Whether you have questions about the report’s scope, methodology, customization options, or which license suits you best, we’re here to assist. Please reach out to us at sales@theinsightpartners.com, and one of our representatives will get in touch promptly.
Yes, a billing invoice will be automatically generated and sent to your registered email upon successful completion of your purchase.
If you need the invoice in a specific format or require additional details (such as company name, GST, or VAT information), feel free to contact us, and we’ll be happy to assist.
Yes, certainly.
If you encounter any difficulties accessing or receiving your report, our support team is ready to assist you. Simply reach out to us via email or live chat with your order information, and we’ll ensure the issue is resolved quickly so you can access your report without interruption.















- Abcam plc
- Agilent Technologies, Inc.
- Bio SB
- BIO-RAD LABORATORIES INC.
- Cell Signaling Technology, Inc.
- Danaher
- F. HOFFMANN-LA ROCHE LTD.
- MERCK KGaA
- PerkinElmer Inc.
- THERMO FISHER SCIENTIFIC INC.


